Category Archives: Global

Refilling the Antibiotic Pipeline: How to Lead the Horse to Water?

Last week, the United States Center for Disease Control (CDC) and Britain’s Chief Medical Officer issued separate warnings about the urgent problem of antibiotic resistance in infectious diseases. Given industry’s general lack of interest in developing new antibiotics to address this problem, the warnings indicate that a discussion is needed around which incentives and regulatory [...]
Also posted in FDA, Market Access, R&D, Regulatory, Safety, Strategy, pricing | Tagged , , , , | 1 Comment

Going Global: The New Pharma Workforce

Mexico and other emerging markets top the skills gap list By Susan Crowley Finding the right people for the right job might seem an afterthought for big Pharma companies that have cut their US workforce by more than 250,000 in the past 10 years.  But the rush is back on for talent:  the challenge is [...]
Also posted in Emerging Markets, Guest Blog | Tagged , , , | 1 Comment

Teva Joins Top 10, “Face” of Big Pharma Changing

Teva’s accession to the exclusive group that is the Pharma Top 10 is further proof, according to IMS Health, that branded pharma needs to renounce its product-protected past and embrace the patient-led, specialty-focused future. As the first non-western, non-innovative-core company to enter pharma’s global Top 10, according to IMS Health research, Teva’s rise to prominence [...]
Also posted in Strategy | Tagged , , , | 1 Comment

Emerging Countries' R&D: A Contest, but No Wipe Out

Emerging country markets are widely viewed as Big Pharma’s ace in the hole to replace declining rates of innovation in the US and Europe, with numerous studies claiming the BRICK nations (the ‘K’ is from South Korea) are at the center of a revolutionary global shift in the source points for new ideas —  what [...]
Also posted in Emerging Markets, IP, R&D | Tagged , , , | 2 Comments

Global Patent Management Made Easy

Patent Management Made Easy Even with a successfully launched start-up or spin-out to your name, you may still be tempted to close your eyes to the complexities of IP. But it’s actually very simple, writes Jason Rutt. So, you have done it. You have left big business or forsaken the dusty halls of academia to launch that [...]
Also posted in Europe, Guest Blog, IP, Legal | Tagged , , , | Leave a comment